The clinical impact of new antiepileptic drugs after a decade of use in epilepsy
- 1 June 2002
- journal article
- review article
- Published by Elsevier in Epilepsy Research
- Vol. 50 (1-2) , 21-32
Abstract
No abstract availableKeywords
This publication has 51 references indexed in Scilit:
- The long-term use of felbamate in children with severe refractory epilepsyEpilepsy Research, 2001
- Life-threatening adverse events of antiepileptic drugsEpilepsy Research, 2001
- EpilepsyNew England Journal of Medicine, 2001
- The process of epileptogenesis: a pathophysiological approachCurrent Opinion in Neurology, 2001
- Oxcarbazepine Placebo‐Controlled, Dose‐Ranging Trial in Refractory Partial EpilepsyEpilepsia, 2000
- Randomised, Placebo‐Controlled Study of Vigabatrin as First‐Line Treatment of Infantile SpasmsEpilepsia, 1999
- Patients with Refractory SeizuresNew England Journal of Medicine, 1999
- Epilepsy, Vagal Nerve Stimulation by the NCP System, Mortality, and Sudden, Unexpected, Unexplained DeathEpilepsia, 1998
- Treatment of Lennox-Gastaut SyndromeCNS Drugs, 1998
- Causes of Epilepsy: Contributions of the Rochester Epidemiology ProjectMayo Clinic Proceedings, 1996